To protect the rights of a particular group, its representatives have to unite and defend their interests. But what if the concerned group is HIV+ children? Parent communities in different EECA countries have been working for a long time, but this year they have established ...

The Medicines Patent Pool (MPP) welcomes its sublicensing partner Mylan’s announcement yesterday that it has received Tentative Approval from the U.S. Food and Drug Administration (USFDA) for generic versions of its combination product tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and dolutegravir (DTG). Mylan signed a licence ...